Intravesical BCG vs GEMDOCE in NMIBC
Clinical trial NCT05538663 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05538663
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-07
- Primary completion
- 2029-11-01
- Enrollment
- 870
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.